Unknown

Dataset Information

0

Recombinant LipL32 Protein Developed Using a Synthetic Gene Detects Leptospira-specific Antibodies in Human Serum Samples.


ABSTRACT: Background:Synthetic biology is emerging as a viable alternative for the production of recombinant antigens for diagnostic applications. It offers a safe alternative for the synthesis of antigenic principles derived from organisms that pose a high biological risk. Methods:Here, we describe an enzyme-linked immunosorbent assay (ELISA) using the synthetic recombinant LipL32 (rLipL32) protein expressed in Escherichia coli for the detection of Leptospira-specific antibodies in human serum samples. The rLipL32-based ELISA was compared with a microscopic agglutination test (MAT), which is currently used as the gold standard for the diagnosis of leptospirosis. Results:Our results showed that all the MAT-positive serum samples were positive for Leptospira-specific IgG in an ELISA, while 65% (n = 13) of these samples were also positive for Leptospira-specific IgM. In the MAT-negative serum samples, 80% and 55% of the samples were detected as negative by an ELISA for Leptospira-specific IgM and IgG, respectively. Conclusion:An ELISA using the synthetic rLipL32 antigen was able to distinguish Leptospira-specific IgM (sensitivity 65% and specificity 80%) and IgG (sensitivity 100% and specificity 55%) in human serum samples and has the potential to serve as a rapid diagnostic test for leptospirosis.

SUBMITTER: Yaakob Y 

PROVIDER: S-EPMC5772814 | biostudies-literature | 2017 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Recombinant LipL32 Protein Developed Using a Synthetic Gene Detects Leptospira-specific Antibodies in Human Serum Samples.

Yaakob Yuszniahyati Y   Rodrigues Kenneth Francis KF   Opook Fernandes F   William Timothy T   John Daisy Vanitha DV  

The Malaysian journal of medical sciences : MJMS 20171026 5


<h4>Background</h4>Synthetic biology is emerging as a viable alternative for the production of recombinant antigens for diagnostic applications. It offers a safe alternative for the synthesis of antigenic principles derived from organisms that pose a high biological risk.<h4>Methods</h4>Here, we describe an enzyme-linked immunosorbent assay (ELISA) using the synthetic recombinant LipL32 (rLipL32) protein expressed in <i>Escherichia coli</i> for the detection of Leptospira-specific antibodies in  ...[more]

Similar Datasets

| S-EPMC3854885 | biostudies-literature
| S-EPMC4214626 | biostudies-literature
| S-EPMC5856796 | biostudies-literature
| S-EPMC5566480 | biostudies-literature
| S-EPMC2650462 | biostudies-literature
| S-EPMC2823465 | biostudies-literature
| S-EPMC7561569 | biostudies-literature
| S-EPMC3971780 | biostudies-literature
| S-EPMC6066729 | biostudies-literature
| S-EPMC8769300 | biostudies-literature